BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 35911741)

  • 1. A Glimpse Into the Microbiome of Sjögren's Syndrome.
    Deng C; Xiao Q; Fei Y
    Front Immunol; 2022; 13():918619. PubMed ID: 35911741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Insights in Microbiome Shifts in Sjogren's Syndrome and Possible Therapeutic Interventions.
    Tsigalou C; Stavropoulou E; Bezirtzoglou E
    Front Immunol; 2018; 9():1106. PubMed ID: 29881381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysbiotic salivary microbiota in dry mouth and primary Sjögren's syndrome patients.
    Rusthen S; Kristoffersen AK; Young A; Galtung HK; Petrovski BÉ; Palm Ø; Enersen M; Jensen JL
    PLoS One; 2019; 14(6):e0218319. PubMed ID: 31211815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gut-eye-lacrimal gland-microbiome axis in Sjögren Syndrome.
    Trujillo-Vargas CM; Schaefer L; Alam J; Pflugfelder SC; Britton RA; de Paiva CS
    Ocul Surf; 2020 Apr; 18(2):335-344. PubMed ID: 31644955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation Between Salivary Microbiome of Parotid Glands and Clinical Features in Primary Sjögren's Syndrome and Non-Sjögren's Sicca Subjects.
    Kim D; Jeong YJ; Lee Y; Choi J; Park YM; Kwon OC; Ji YW; Ahn SJ; Lee HK; Park MC; Lim JY
    Front Immunol; 2022; 13():874285. PubMed ID: 35603219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can Gut Microbiota Affect Dry Eye Syndrome?
    Moon J; Yoon CH; Choi SH; Kim MK
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthy Patients Are Not the Best Controls for Microbiome-Based Clinical Studies: Example of Sjögren's Syndrome in a Systematic Review.
    Doaré E; Héry-Arnaud G; Devauchelle-Pensec V; Alegria GC
    Front Immunol; 2021; 12():699011. PubMed ID: 34394092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into Microbiota in Sjögren's Syndrome.
    Mieliauskaitė D; Kontenis V
    Medicina (Kaunas); 2023 Sep; 59(9):. PubMed ID: 37763780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological Analysis of Ocular Lesions in a Murine Model of Sjögren's Syndrome.
    Ushio A; Arakaki R; Eguchi H; Hotta F; Yamada A; Kudo Y; Ishimaru N
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysbiosis of the buccal mucosa microbiome in primary Sjögren's syndrome patients.
    van der Meulen TA; Harmsen HJM; Bootsma H; Liefers SC; Vich Vila A; Zhernakova A; Fu J; Wijmenga C; Spijkervet FKL; Kroese FGM; Vissink A
    Rheumatology (Oxford); 2018 Dec; 57(12):2225-2234. PubMed ID: 30060225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologic therapy in Sjögren's syndrome.
    Shao Q
    Clin Rheumatol; 2021 Jun; 40(6):2143-2154. PubMed ID: 33106929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in imaging of the lacrimal gland in Sjögren's syndrome: A narrative review.
    Zhong W; Zhang H; Ran H
    J Clin Ultrasound; 2024 Jan; 52(1):68-77. PubMed ID: 37907965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of Labial Gland Mesenchymal Stem Cells of Healthy Individuals and Patients with Sjögren's Syndrome: A Preliminary Study.
    Wang SQ; Wang YX; Hua H
    Stem Cells Dev; 2017 Aug; 26(16):1171-1185. PubMed ID: 28537471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Gut-Eye Axis: Correlation Between the Gut Microbiota and Autoimmune Dry Eye in Individuals With Sjögren Syndrome.
    Bai X; Xu Q; Zhang W; Wang C
    Eye Contact Lens; 2023 Jan; 49(1):1-7. PubMed ID: 36544282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of Aquaporins in the Pathogenesis, Diagnosis and Treatment of Sjögren's Syndrome.
    Soyfoo MS; Chivasso C; Perret J; Delporte C
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The autoimmunity-oral microbiome connection.
    Nikitakis NG; Papaioannou W; Sakkas LI; Kousvelari E
    Oral Dis; 2017 Oct; 23(7):828-839. PubMed ID: 27717092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Mechanisms Linking Inflammation to Autoimmunity in Sjögren's Syndrome: Identification of New Targets.
    Sisto M; Ribatti D; Lisi S
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis.
    Beckman KA; Luchs J; Milner MS; Ambrus JL
    Adv Ther; 2017 Apr; 34(4):799-812. PubMed ID: 28283891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Involvement of Alarmins in the Pathogenesis of Sjögren's Syndrome.
    Sarrand J; Baglione L; Parisis D; Soyfoo M
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Updates in diagnostics, treatments, and correlations between oral and ocular manifestations of Sjogren's syndrome.
    Choudhry HS; Hosseini S; Choudhry HS; Fatahzadeh M; Khianey R; Dastjerdi MH
    Ocul Surf; 2022 Oct; 26():75-87. PubMed ID: 35961534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.